Literature DB >> 1287475

Nucleotide sequence of bup, an upstream gene in the bmi-1 proviral insertion locus.

Y Haupt1, G Barri, J M Adams.   

Abstract

The ability of Moloney murine leukemia virus to accelerate lymphomagenesis in E mu-myc transgenic mice is frequently associated with proviral integration within a locus denoted bmi-1. This locus contains not only the bmi-1 gene implicated as a collaborator with myc in lymphomagenesis but also just upstream an unknown gene denoted bup. The nucleotide sequence reported here for bup cDNA and flanking genomic sequences reveals that this widely expressed gene comprises at least 7 exons and potentially encodes a polypeptide of 195 amino acid residues. Computer searches with this polypeptide sequence revealed no close homolog in the databases, nor any conserved motifs, and it is unrelated to the product of the mel-13 gene, which lies just upstream from the bmi-1 homolog mel-18.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287475     DOI: 10.1007/bf01006395

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  11 in total

1.  Expression of novel DNA-binding protein with zinc finger structure in various tumor cells.

Authors:  M Tagawa; T Sakamoto; K Shigemoto; H Matsubara; Y Tamura; T Ito; I Nakamura; A Okitsu; K Imai; M Taniguchi
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

Review 2.  Tumorigenesis by slow-transforming retroviruses--an update.

Authors:  M van Lohuizen; A Berns
Journal:  Biochim Biophys Acta       Date:  1990-12-11

Review 3.  Oncogenes at viral integration sites.

Authors:  G Peters
Journal:  Cell Growth Differ       Date:  1990-10

4.  The bmi-1 and mel-18 gene products define a new family of DNA-binding proteins involved in cell proliferation and tumorigenesis.

Authors:  M G Goebl
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

5.  Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice.

Authors:  Y Haupt; W S Alexander; G Barri; S P Klinken; J M Adams
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

6.  Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.

Authors:  M van Lohuizen; S Verbeek; B Scheijen; E Wientjens; H van der Gulden; A Berns
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

7.  Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.

Authors:  Y Haupt; A W Harris; J M Adams
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

8.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

10.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

View more
  3 in total

Review 1.  The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer.

Authors:  Michael Zeidler; Celina G Kleer
Journal:  J Mol Histol       Date:  2006-07-20       Impact factor: 2.611

2.  Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental Factors.

Authors:  Edmond J Yunis; Joaquin Zúñiga; Prasad S Koka; Zaheed Husain; Viviana Romero; Joel N H Stern; Masha Fridkis-Hareli
Journal:  J Stem Cells       Date:  2006

3.  The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells.

Authors:  Michael Zeidler; Sooryanarayana Varambally; Qi Cao; Arul M Chinnaiyan; David O Ferguson; Sofia D Merajver; Celina G Kleer
Journal:  Neoplasia       Date:  2005-11       Impact factor: 5.715

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.